ENANTA PHARMACEUTICALS INC Quarterly Common Stock, Shares, Issued from Q3 2012 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Enanta Pharmaceuticals Inc quarterly Common Stock, Shares, Issued history and growth rate from Q3 2012 to Q2 2024.
  • Enanta Pharmaceuticals Inc Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 21.2M shares, a 0.6% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 21.2M +126K +0.6% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 21.2M +130K +0.62% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 21.2M +272K +1.3% Dec 31, 2023 10-Q 2024-02-08
Q3 2023 21.1M +268K +1.29% Sep 30, 2023 10-Q 2024-08-07
Q2 2023 21.1M +336K +1.62% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 21M +431K +2.09% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 20.9M +378K +1.84% Dec 31, 2022 10-Q 2023-02-08
Q3 2022 20.8M +553K +2.73% Sep 30, 2022 10-K 2023-11-22
Q2 2022 20.7M +509K +2.52% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 20.6M +433K +2.15% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 20.5M +364K +1.81% Dec 31, 2021 10-Q 2022-02-10
Q3 2021 20.2M +161K +0.8% Sep 30, 2021 10-K 2022-11-23
Q2 2021 20.2M +141K +0.7% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 20.2M +199K +1% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 20.1M +332K +1.68% Dec 31, 2020 10-Q 2021-02-09
Q3 2020 20.1M +374K +1.9% Sep 30, 2020 10-K 2021-11-24
Q2 2020 20.1M +388K +1.97% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 20M +317K +1.61% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 19.8M +375K +1.93% Dec 31, 2019 10-Q 2020-02-10
Q3 2019 19.7M +308K +1.59% Sep 30, 2019 10-K 2020-11-25
Q2 2019 19.7M +322K +1.66% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 19.7M +409K +2.12% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 19.4M +285K +1.49% Dec 31, 2018 10-Q 2019-02-08
Q3 2018 19.4M +275K +1.44% Sep 30, 2018 10-K 2019-11-27
Q2 2018 19.4M +270K +1.41% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 19.3M +206K +1.08% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 19.2M +110K +0.58% Dec 31, 2017 10-Q 2018-02-09
Q3 2017 19.1M +84K +0.44% Sep 30, 2017 10-K 2018-11-29
Q2 2017 19.1M +54.2K +0.29% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 19.1M +97.4K +0.51% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 19M +245K +1.3% Dec 31, 2016 10-Q 2017-02-09
Q3 2016 19M +319K +1.71% Sep 30, 2016 10-K 2017-12-11
Q2 2016 19M +119K +0.63% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 19M +57.4K +0.3% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 18.8M -26.9K -0.14% Dec 31, 2015 10-Q 2016-02-09
Q3 2015 18.7M -86.6K -0.46% Sep 30, 2015 10-K 2016-12-09
Q2 2015 18.9M +127K +0.68% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 18.9M +213K +1.14% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 18.8M +647K +3.56% Dec 31, 2014 10-Q 2015-02-06
Q3 2014 18.8M +665K +3.67% Sep 30, 2014 10-K 2015-12-11
Q2 2014 18.8M +755K +4.18% Jun 30, 2014 10-Q 2014-08-12
Q1 2014 18.7M +659K +3.66% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 18.2M Dec 31, 2013 10-Q 2014-02-13
Q3 2013 18.1M +16.8M +1250% Sep 30, 2013 10-K 2014-12-11
Q2 2013 18M Jun 30, 2013 10-Q 2013-08-12
Q1 2013 18M Mar 31, 2013 10-Q 2013-05-15
Q3 2012 1.34M Sep 30, 2012 10-K 2013-12-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.